Your browser doesn't support javascript.
loading
Selective Intracellular Delivery of Thiolated Cargo to Tumor and Neovasculature Cells Using Histidine-Rich Peptides as Vectors.
Eksteen, J Johannes; Ausbacher, Dominik; Vasskog, Terje; Rekdal, Øystein; Svendsen, John S M.
Afiliação
  • Eksteen JJ; NORCE Norwegian Research Centre AS, Siva Innovasjonssenter, Sykehusvegen 21, NO 9294 Tromsø, Norway.
  • Ausbacher D; Department of Pharmacy, UiT Arctic University of Norway, NO 9037 Tromsø, Norway.
  • Vasskog T; NORCE Norwegian Research Centre AS, Siva Innovasjonssenter, Sykehusvegen 21, NO 9294 Tromsø, Norway.
  • Rekdal Ø; Lytix Biopharma AS, Siva Innovasjonssenter, Sykehusvegen 21, P.O. Box 6447, NO 9294 Tromsø, Norway.
  • Svendsen JSM; Department of Chemistry, UiT Arctic University of Norway, NO 9037 Tromsø, Norway.
ACS Omega ; 5(10): 4937-4942, 2020 Mar 17.
Article em En | MEDLINE | ID: mdl-32201779
Short histidine-rich peptides could serve as novel activatable vectors for delivering cytotoxic payloads to tumor and neovasculature cells. This explorative study reports preliminary results showing that zinc ions, which are found in elevated levels at neovasculature sites, can trigger the intracellular delivery of a short antimicrobial peptide when conjugated to a histidine-rich peptide through a disulfide bond. The importance of exofacial thiols in the mode of action of these disulfide-linked conjugates is also shown.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article